These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14080728)

  • 21. Relationship of fibrinogen B to thromboembolic phenomena.
    RYAN EA
    Can Med Assoc J; 1951 Mar; 64(3):237-40. PubMed ID: 14801758
    [No Abstract]   [Full Text] [Related]  

  • 22. COAGULATION STUDIES IN EXTRACORPOREAL CIRCULATION.
    DYBKJAER E; BERG E; KISSMEYER-NIELSEN F
    Acta Chir Scand; 1964 Oct; 128():350-61. PubMed ID: 14211290
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [STUDIES ON THE CONDITIONS FOR THE FORMATION OF URINARY CYLINDERS].
    FREY J; JUERGENS J
    Med Klin; 1964 Apr; 59():560-7. PubMed ID: 14197215
    [No Abstract]   [Full Text] [Related]  

  • 25. [ON THE STABILITY OF THE AGENT INDUCING INCREASED BLOOD COAGULATION AFTER ACUTE BLOOD LOSS].
    ZUBAIROV DM
    Vopr Med Khim; 1963; 9():621-6. PubMed ID: 14150511
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relations between the concentration of fibrinogen, thromboplastin time, thrombin time and reptilase time in patients treated with Arwin].
    Paar D; Klüken N
    Med Welt; 1975 Sep; 26(38):1700-1. PubMed ID: 1186461
    [No Abstract]   [Full Text] [Related]  

  • 27. ANTIHEMOPHILIC FACTOR: ITS PRESENCE IN FIBRINOGEN, ASSAY PROBLEMS AND THE STABILITY OF LYOPHILIZED AHF-FIBRINOGEN PREPARATIONS.
    BAUMGARTEN W; SANDERS BE; BELKIN BD; PAGENKEMPER FE; ALBERS WG; CIMINERA JL
    Thromb Diath Haemorrh; 1963 Jul; 143():354-67. PubMed ID: 14081259
    [No Abstract]   [Full Text] [Related]  

  • 28. ADENOSINE TRIPHOSPHATE: AN INHIBITOR OF GENERATION OF THROMBOPLASTIN.
    PILGERAM LO
    Nature; 1963 Aug; 199():708-9. PubMed ID: 14074572
    [No Abstract]   [Full Text] [Related]  

  • 29. [COAGULATION RESEARCH AND ITS CLINICAL SIGNIFICANCE].
    AMRIS CJ
    Manedsskr Prakt Laegegern; 1963 Dec; 41():484-503. PubMed ID: 14099118
    [No Abstract]   [Full Text] [Related]  

  • 30. Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist.
    Kjalke M; Kjellev S; Rojkjaer R
    J Thromb Haemost; 2007 Apr; 5(4):774-80. PubMed ID: 17229056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [BLOOD COAGULATION CHANGES AND THEIR RELATION TO THE EFFECT OF DRUGS IN HYPERTENSION].
    URBANIUK KG
    Kardiologiia; 1964; 4():45-8. PubMed ID: 14203916
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thromboses and haemorrhages in geriatrics (author's transl)].
    de Nicola PE
    Z Alternsforsch; 1976; 31(6):553-8. PubMed ID: 1014738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ON QUANTITATIVE CHANGES IN FIBRINOGEN AND METHODS OF THEIR EXAMINATION].
    BALUDA VP; RUSAKOVA GP; TOKAREV OIu
    Lab Delo; 1964; 10():425-9. PubMed ID: 14258534
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of reptilase and thrombin on human blood platelets and observations on the molecular mechanism of clot retraction.
    Morse EE; Jackson DP; Conley CL
    J Lab Clin Med; 1967 Jul; 70(1):106-15. PubMed ID: 6067447
    [No Abstract]   [Full Text] [Related]  

  • 35. [METABOLIC PROBLEMS OF ATHEROSCLEROSIS. III. ATHEROSCLEROSIS AND BLOOD COAGULATION].
    SIMON KH
    Med Monatsschr; 1963 Sep; 17():560-4. PubMed ID: 14052143
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of tyrosinase on certain components of the blood clotting system.
    KRUGELIS EJ; SIZER IW
    Blood; 1954 May; 9(5):513-9. PubMed ID: 13149632
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of physical variables on adhesion in clots formed from fibrinogen and thrombin.
    MORRISON PR; SEILER A
    Am J Physiol; 1952 Feb; 168(2):421-9. PubMed ID: 14903158
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of fibrin formation in exercise-induced activation of coagulation.
    Vogt A; Hofmann V; Straub PW
    Am J Physiol; 1979 Apr; 236(4):H577-9. PubMed ID: 434223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Microscopic modifications of the fibrinous clot in relation to the plasma modifications; variations in the thrombin-fibrinogen reaction].
    CHAMPY C; FIEHRER A; DEMAY M
    Presse Med (1893); 1952 Aug; 60(52):1107-9. PubMed ID: 13026904
    [No Abstract]   [Full Text] [Related]  

  • 40. The hemostatic mechanism and its defects.
    Macfarlane RG
    Int Rev Exp Pathol; 1968; 6():55-133. PubMed ID: 4884086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.